Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-445-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well-documented study report which meets basic scientific principles.
Data source
Reference
- Reference Type:
- publication
- Title:
- Dermal absorption and distribution of topically dosed jet fuels Jet-A, JP-8, and JP-8(100)
- Author:
- Riviere, Jim E.,Brooks, James D., Monteiro-Riviere , Nancy A., Budsaba, Kamon, Smith, Charles E.
- Year:
- 1 999
- Bibliographic source:
- Toxicology and Applied Pharmacology 160: 60-75
Materials and methods
- Principles of method if other than guideline:
- In vitro isolated perfused porcine skin flap (IPPSF) Studies.
- GLP compliance:
- not specified
Test material
- Radiolabelling:
- yes
- Remarks:
- 14C-naphthalene, 3H-dodecane, 14C- hexadecane
Test animals
- Species:
- pig
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- in vitro experiment
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 5 hours; 4 trials
- Doses:
- 25 uL of Jet fuel with radio labeled tracers
- Control animals:
- no
- Details on study design:
- In vitro isolated perfused porcine skin flap (IPPSF) Studies.
In these studies, jet fuel mixtures were applied non-occluded to mimic field exposure conditions, and experiments were conducted for a total of 5 h in IPPSFs with 4 replicates per treatment condition. A 1 x 5 cm dosing area was drawn on the surface of the skin flap with a surgery marker. A dose, containing 25 uL of the specified jet fuel containing approximately 2 uCi of 14C-naphthalene plus 10 uCi of 3H-dodecane and 14C- hexadecane was applied directly to the surface of the skin flap. The specific activities of the marker compounds were sufficient that the added radio labeled compounds had little effect on the final concentration of naphthalene (1.21% instead of 1.1%) and dodecane (4.701% instead of 4.7%).
Perfusate samples (3 ml) were collected every 5 min for the first 40 min then every 10 mm until 1.5 h. and then every 15 min until termination at 5 h. At termination, several samples were taken for mass balance of the marker compounds. The surface of the dose area was swabbed twice with a 1% soap solution and gauze, and then 12 stratum corneum tape strips were collected using cellophane tape (3M Corporation, Minneapolis. MN). The entire dose area was removed. A 1x 1 cm core of the dose area was removed and frozen for subsequent depth of penetration studies. This consisted of laying the core sample epidermal side down in an aluminum foil boat and embedding in Tissue-Tek OCT compound (Miles. Inc., Elkhart, IN), snap freezing in liquid nitrogen, followed by sectioning (40 cm) on a Reichart-Jung Model 1800 Cryocut (Warner Lambert, Buffalo, NY). The remaining dosed area as well as the surrounding skin was separated from the fat and held for analysis. All samples (including swabs, tape strips, core sections, skin, fat, mass balance samples, etc.) were dissolved separately in Soluene. A representative volume of each sample was oxidized completely via a Packard Model 307 Tissue Oxidizer. The 3H and 14C samples were counted separately on a Packard Model 1900TR TriCarb Scintillation Counter.
Data analysis. Data was entered into a custom IPPSF database and the resulting analysis reported. Since all experiments were conducted using the identical marker doses across all fuels, and the absolute concentrations of these marker compounds were similar, these results are expressed as percentage applied dose to give a representative assessment of the absorption and cutaneous penetration of a complex mixture such as jet fuel. This is appropriate since the absolute concentrations of jet fuel hydrocarbons are not fixed across all fuels due to differences that arise from the natural source of the petroleum and different refining processes. Area under the curve (AUC) in the perfusate was calculated using the trapezoidal method. Peak flux was the maximum flux (% dose/mm) observed at any one time point.
The experimental compartments which were analyzed in these studies used the following definitions: (1) Surface is the residue removed by washing the surface of the IPPSF at termination of the experiment plus the residues remaining in the dosing template. (2) Stratum corneum is the residue extracted from the outermost stratum corneum via 12 tape strips at the termination of the experiment. (3) Dosed skin is the residue that remained in the dosed skin plus the depth of penetration core taken at termination. (4) Absorption is the cumulative amount of the marker compound collected in the effluent over the course of the 5-h experiment. (5) Fat is the residue remaining in the fat when it was separated from the dermis at the end of the experiment. (6) Penetration is the summation of the label in the effluent plus skin plus fat, but not stratum corneum or surface. (7) Evaporative loss is that label which was lost to evaporation. Previous studies using IPPSF’s indicated that the penetration estimate is the best empirical correlate to predict eventual in vivo absorption in humans.
Statistical significance of absorption and penetration parameters were determined using ANOVA or by a priori-defined orthogonal contrasts where appropriate at the 0.05 level of significance. A least significant difference (LSD) procedure was used for multiple comparisons on overall tissue disposition. - Details on in vitro test system (if applicable):
- A 1 x 5 cm dosing area was drawn on the surface of the skin flap with a surgery marker. A dose, containing 25 uLof the specified jet fuel containing approximately 2 uCi of 14C-naphthalene plus 10 uCi of 3H-dodecane and 14C- hexadecane was applied directly to the surface of the skin flap. Perfusate samples (3 ml) were collected every 5 min for the first 40 min then every 10 min until 1.5 hours and then every 15 min until termination at 5 hours. At termination, several samples were taken for mass balance of the marker compounds. The surface of the dose area was swabbed twice with a 1% soap solution and gauze, and then 12 stratum corneum tape strips were collected using cellophane tape (3M Corporation, Minneapolis. MN). The entire dose area was removed. A 1x 1 cm core of the dose area was removed and frozen for subsequent depth of penetration studies. This consisted of laying the core sample epidermal side down in an aluminum foil boat and embedding in Tissue-Tek OCT compound (Miles. Inc., Elkhart, IN), snap freezing in liquid nitrogen, followed by sectioning (40 cm) on a Reichart-Jung Model 1800 Cryocut (Warner Lambert, Buffalo, NY). The remaining dosed area as well as the surrounding skin was separated from the fat and held for analysis.
Results and discussion
- Signs and symptoms of toxicity:
- not examined
- Dermal irritation:
- not examined
- Absorption in different matrices:
- Within JP-8, the rank order of absorption for all marker components was (mean +/- SEM; % dose) naphthalene (1.17 +/- 0.07) > dodecane (0.63 +/- 0.04) > hexadecane (0.18 +/- 0.08)
- Total recovery:
- Not indicated
- Conversion factor human vs. animal skin:
- 1
Applicant's summary and conclusion
- Conclusions:
- Within JP-8, the rank order of absorption for all marker components was (mean +/- SEM; % dose) naphthalene (1.17 +/- 0.07)> dodecane (0.63 +/- 0.04) > hexadecane (0.18 +/- 0.08). The area under the curve (AUC) was determined to be (mean +/- SEM; % dose-h/mL): naphthalene (0.0199 +/- 0.0020)> dodecane (0.0107 +/- 0.0009) > hexadecane (0.0017 +/- 0.0003). In contrast, deposition within dosed skin showed the reverse pattern.
- Executive summary:
The percutaneous absorption and cutaneous disposition of topically applied neat Jet-A, JP-8, and JP-8(100) jet fuels (25 uL/5 cm2) was examined by monitoring the absorptive flux of the marker components 14C naphthalene and 4H dodecane simultaneously applied non-occluded to isolated perfused porcine skin flaps (a = 4). Absorption of 14C hexadecane was estimated from JP-8 fuel. Absorption and disposition of naphthalene and dodecane were also monitored using a nonvolatile JP-8 fraction reflecting exposure to residual fuel that might occur 24 h after a jet fuel spill. In all studies, perfusate, stratum corneum, and skin concentrations were measured over 5 h. Naphthalene absorption had a clear peak absorptive flux at less than 1 h, while dodecane and hexadecane had prolonged, albeit significantly lower, absorption flux profiles. Within JP-8, the rank order of absorption for all marker components was (mean +/- SEM; % dose) naphthalene (1.17 +/- 0.07) > dodecane (0.63 +/- 0.04) > hexadecane (0.18 +/- 0.08). The area under the curve (AUC) was determined to be (mean +/- SEM; % dose-h/mL): naphthalene (0.0199 +/- 0.0020) > dodecane (0.0107 +/- 0.0009) > hexadecane (0.0017 +/- 0.0003). In contrast, deposition within dosed skin showed the reverse pattern.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.